AMRX   $5.87  5.19% Market Closed

Amneal Pharmaceuticals Inc
Total Cash 93.74M
totalCashPerShare 0.305
EBITDA 500.78M
Total Debt 2.75B
quickRatio 0.873
currentRatio 1.628
Total Revenue 2.39B
debtToEquity 4486.694
Revenue/Share 13.59
ROA 0.04665
ROE -0.36058998
grossProfits
freeCashflow 303.90M
operatingCashflow 345.58M
earningsGrowth
revenueGrowth 0.012
grossMargins 0.36091
ebitdaMargins 0.20922
operatingMargins 0.13192001
profitMargins -0.03509
enterpriseValue 4.58B
forwardPE 9.181818
floatShares 123.43M
sharesOutstanding 308.55M
sharesShort 2.07M
sharesShortPriorMonth 2.10M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.36%
Short Ratio help_outline 1.32%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.065
Price To Book help_outline 93.23
earningsQuarterlyGrowth
netIncomeToCommon -83.99M
trailingEps -0.48%
forwardEps 0.66%
enterpriseToEbitda 9.14
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.09 1Q 2024
institutionsCount 203
lastUpdated April 1, 2024, 2:16 p.m.